Kathleen R Cho

 Kathleen cho
Peter A. Ward Professor of Pathology
Associate Chair for Academic Affairs
Department of Pathology
Medical Director, Gynecologic Pathology
Professor of Pathology and Professor of Internal Medicine
[email protected]
Available to mentor
Kathleen R Cho
Kathleen cho
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Journal Article
      Cancer During Pregnancy: Navigating Clinical and Research Challenges
      Callaway MK, Comfort L, Anandan D, Sharma R, Florez N, Lyons TR, Germain D, Cho KR, Rochelson BL, Bonanno C, Oktay K, Roychoudhury S, O’donnell E, Barakat R, Marquardt J, Bianchi DW, Cardonick E, Norton L, Partridge AH, Domchek SM, Borges VF, Amant F, Dos Santos CO. Current Oncology, 2026 May 1; 33 (5): DOI:10.3390/curroncol33050296
      PMID: 42187613
    • Journal Article
      High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human disease
      Szabova L, Lu L, Gordon MB, Johnson K, Guerin TM, Bassel L, Householder DB, Edouard M, Ries A, Kozlov S, Collins NK, Custer W, Cho K, Samimi G, Shoemaker RH, Weaver Ohler Z. Iscience, 2026 Jan 16; 29 (1): DOI:10.1016/j.isci.2025.114238
    • Journal Article
      Medroxyprogesterone Acetate Inhibits Tumorigenesis in Mouse Models of Oviductal High-Grade Serous Carcinoma.
      Zhai Y, Bedi K, Wu R, Feng Y, Green ME, Pearce CL, Pike MC, Fearon ER, Cho KR. Cancers (Basel), 2025 Oct 28; 17 (21): DOI:10.3390/cancers17213456
      PMID: 41228249
    • Journal Article
      Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma
      Zhai Y, Fearon ER, Cho KR. Cancers, 2025 Aug 27; 17 (17): 2759 DOI:10.3390/cancers17172759
    • Journal Article
      SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction.
      Feng Y, Zhu N, Bedi K, Li J, Perera C, Green M, Assarzadegan N, Zhai Y, Liu Q, Baladandayuthapani V, Spence JR, Cho KR, Fearon ER. J Clin Invest, 2025 Jun 2; 135 (11): DOI:10.1172/JCI184115
      PMID: PMC12126244
    • Journal Article
      Abstract 5173: Heterozygous Ppp2r1a mutations with concurrent loss of Tp53 drive invasive high-grade uterine cancer
      O'Connor CM, Barrie K, Zawacki K, Bergin IL, Onishi GH, DiFeo A, Cho K, Saunders T, Narla G. Cancer Research, 2025 Apr 24; 85 (8_Supplement_1): 5173 - 5173. DOI:10.1158/1538-7445.am2025-5173
    • Journal Article
      Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.
      Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, Liao P, Zhou J, Okla K, Lin H, Lin X, Grove S, Wei S, Vatan L, Hu J, Szumilo J, Kotarski J, Freeman ZT, Skala S, Wicha M, Cho KR, Chinnaiyan AM, Schon S, Wen F, Kryczek I, Wang S, Chen L, Zou W. Cell, 2024 Aug 22; 187 (17): 4713 - 4732.e19. DOI:10.1016/j.cell.2024.06.012
      PMID: PMC11344674
    • Journal Article
      Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.
      Beddows I, Fan H, Heinze K, Johnson BK, Leonova A, Senz J, Djirackor S, Cho KR, Pearce CL, Huntsman DG, Anglesio MS, Shen H. Cancer Res, 2024 Jan 2; 84 (1): 26 - 38. DOI:10.1158/0008-5472.CAN-23-1362
      PMID: PMC10758692